Skip to main content

ENANTA PHARMACEUTICALS INC

Qualité des données : 100%
ENTA
NASDAQ Manufacturing Chemicals
14,11 €
▲ 0,16 € (1,15%)
Cap. Boursière: 403,37 M
Prix
13,90 €
Cap. Boursière
403,37 M
Fourchette du Jour
Fourchette 52 Semaines
Volume
Ouverture —
Moyenne 50J / 200J
Moyenne 50J / 200J

Quick Summary

Points Clés

Revenue declined -9,43% annually over 5 years
Negative free cash flow of -44,01 M
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 6,01%

Croissance

Revenue Growth (5Y)
-9,43%
En dessous de la moyenne du secteur (1,82%)
Revenue (1Y)-3,42%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Qualité

Return on Equity
-91,15%
En dessous de la moyenne du secteur (-53,58%)
ROIC-28,20%
Net Margin-111,78%
Op. Margin-115,09%

Sécurité

Debt / Equity
N/A
Current Ratio4,44
Interest Coverage-8,97

Valorisation

PE (TTM)
-4,30
En dessous de la moyenne du secteur (-1,48)
P/B Ratio3,19
EV/EBITDAN/A
Dividend YieldN/A

Historique des Prix

Tendances Financières

Comparaison Sectorielle

vs médiane du secteur Manufacturing (1366 pairs)
Métrique Action Médiane du Secteur
P/E -4,3 -1,5
P/B 3,2 1,6
ROE % -91,2 -53,6
Net Margin % -111,8 -41,5
Rev Growth 5Y % -9,4 1,8
D/E 0,3

Objectif de Cours des Analystes

6 analystes
Buy
Actuel
14,11 €
+31.1%
Objectif
18,50 €
12,00 €
20,00 €
20,00 €
Prévisions
P/E Prévisionnel -6,39
BPA Prévisionnel -2,21 €
CA Est. 65,87 M

Estimations de Bénéfices

Période BPA Est. CA Est. Analystes
FY2027 -2,21 €
-3,08 € – -1,60 €
65,87 M 5
FY2026 -2,13 €
-2,55 € – -1,31 €
66,40 M 4

Surprises de Résultats

Derniers 5 trimestres
Trimestre BPA Est. BPA Réel Surprise
Q42025 -0,88 € -0,42 € +52,1%
Q32025 -1,01 € -0,87 € +13,9%
2026-Q1 -0,51 € -0,42 € +17,2%
Q22025 -0,89 € -0,85 € +4,0%
Q12025 -1,14 € -1,06 € +6,7%

ETFs Holding This Stock

SHISX SHISX
0,10% weight
SHSCX SHSCX
0,10% weight
SHSAX SHSAX
0,10% weight
BRSIX BRSIX
0,08% weight
GSATX GSATX
0,07% weight
GSCTX GSCTX
0,07% weight
GTTUX GTTUX
0,07% weight
GTTTX GTTTX
0,07% weight
GSXPX GSXPX
0,07% weight
GTTRX GTTRX
0,07% weight

All Fundamental Metrics

Growth
Revenue Growth (1Y) -3,42% Revenue Growth (3Y) -9,18%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) -9,43% Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 83,94 M Net Income (TTM) -93,83 M
ROE -91,15% ROA -29,76%
Gross Margin N/A Operating Margin -115,09%
Net Margin -111,78% Free Cash Flow (TTM) -44,01 M
ROIC -28,20% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 4,44
Interest Coverage -8,97 Asset Turnover 0,27
Working Capital 153,96 M Tangible Book Value 126,59 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -4,30 Forward P/E N/A
P/B Ratio 3,19 P/S Ratio 4,81
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -10,91%
Market Cap 403,37 M Enterprise Value 365,93 M
Per Share
EPS (Diluted TTM) -4,26 Revenue / Share 2,89
FCF / Share -1,52 OCF / Share -1,07
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue 15,53% FCF Conversion 46,91%
SBC-Adj. FCF -67,77 M Growth Momentum 6,01

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 65,32 M 67,64 M 79,20 M 86,16 M 97,07 M
Net Income -81,89 M -116,05 M -133,82 M -121,76 M -79,00 M
EPS (Diluted) -3,84 -5,48 -6,38 -5,91 -3,92
Gross Profit
Operating Income -85,35 M -121,69 M -137,21 M -123,84 M -109,57 M
EBITDA
R&D Expenses 106,74 M 131,48 M 163,52 M 164,52 M 174,11 M
SG&A Expenses
D&A 4,59 M 2,34 M 2,37 M 2,97 M 3,33 M
Interest Expense 7,68 M 10,94 M 5,15 M
Income Tax -1,66 M -1,74 M 2,82 M -433 000,0 -28,58 M

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 280,73 M 376,65 M 462,28 M 375,41 M 438,79 M
Total Liabilities 216,02 M 247,84 M 245,54 M 54,08 M 39,36 M
Shareholders' Equity 64,72 M 128,81 M 216,74 M 321,33 M 399,43 M
Total Debt
Cash & Equivalents 32,30 M 37,23 M 85,39 M 43,99 M 57,21 M
Current Assets 204,34 M 299,85 M 422,79 M 311,71 M 319,02 M
Current Liabilities 48,56 M 57,54 M 62,79 M 29,83 M 36,17 M